Photo taken from TCH Pediatric Hematology Oncology Fellowship/X
Aug 2, 2024, 09:40
Treatment-related hearing loss in medulloblastoma – TCH Pediatric Hematology Oncology Fellowship
TCH Pediatric Hematology Oncology Fellowship shared on X:
“Findings in Neuro-Oncology (Oxford Academic) byand colleagues reveal for medulloblastoma that a patient’s age and the radiation dose to the cochlea inner ear are key risk factors for treatment-related hearing loss.”
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma
Autors: Mohammad H Abu-Arja, Austin L Brown, Jack M Su, M Fatih Okcu, Holly B Lindsay, Susan L McGovern, Mary Frances McAleer, David R Grosshans, Murali M Chintagumpala, Arnold C Paulino
